Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

November 17, 2026

India’s DeepTech Capital Needs People Who Can Put It to Work

November 17, 2026
Facebook X (Twitter) Instagram
Trending
  • Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore
  • Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027
  • India’s DeepTech Capital Needs People Who Can Put It to Work
  • Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput
  • Bench Mark Infotech Services Limited Reports H1 FY27 Results
  • Raise Money Ventures Lights Up Noida’s Startup Ecosystem with a Festive Diwali Networking Celebration
  • After the Success Of His memoir ‘One Fine Day’, Author Sameer Bhide Embarks On His Second Book
  • Global Schools Group Opens Applications for its fully-funded Global Citizen Scholarship 2027
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Health»Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases
Health

Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases

By July 10, 2023No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Faridabad/Aligarh [India], July 10: Dr Luca Testa, a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy, has successfully conducted a series of educational workshops on the effectiveness of Abluminus DES+ in complex percutaneous coronary intervention. These workshops, organized by Concept Medical as part of their educational initiative, showcased the superior capabilities of Abluminus DES+ in treating complex lesions and diffuse disease in angioplasty.

The first workshop was held on 3rd July 2023 at Jawaharlal Nehru Medical College and Hospital (Aligarh Muslim University) in collaboration with Dr Asif Hasan and Dr Azharuddin Malik. The second workshop took place on 4th July 2023 at Fortis Escorts Hospital, Faridabad, with the participation of Dr Sanjay Kumar alongside Dr. Luca Testa.

Dr. Luca Testa expressed his satisfaction with the outcomes achieved using Abluminus DES+ in all the workshops conducted in various Indian institutions. The cases involved patients with complex coronary disease, including chronic total occlusions (CTOs) and severe in-stent restenosis.

“Abluminus DES+ has been my choice of stent for many years, particularly in complex cases, and the results have been promising,” stated Dr. Luca Testa during a press conference. “This unique combination of a drug-coated balloon and a bioresorbable polymer sirolimus-eluting stent offers distinct advantages, especially when treating complex and diffuse disease. It is noteworthy that interventional cardiology is undergoing a significant paradigm shift. Despite the availability of advanced DES technologies like Abluminus DES+, we are progressively changing our approach, considering alternative options such as the Sirolimus-coated balloon Magic Touch. I firmly believe that in the future, we will witness a further implementation of drug-coated balloon technology in our daily practice, either alongside or even independently of stent usage. Abluminus is undoubtedly one of the finest technologies available, especially for complex cases.”

Dr. Luca Testa’s workshops have provided valuable insights into the efficacy and potential of Abluminus DES+ in complex angioplasty procedures. With these educational initiatives, Concept Medical and Dr Testa aim to enhance the knowledge and expertise of healthcare professionals in India, ultimately leading to improved patient outcomes and advancing the field of interventional cardiology.

Explaining the innovation, Concept Medical’s Founder & MD, Dr Manish Doshi, said, “In several patients with type II diabetes and coronary heart disease, there is as recurrence of major adverse cardiac events (MACE) like heart attack, stroke and restenosis (narrowing of unblocked artery after operation). This abluminal drug-eluting stent DES+ will considerably reduce the chances of recurrence.”

About Dr. Luca Testa:

Dr. Luca Testa is a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy. With extensive experience in complex coronary interventions, Dr. Testa has been instrumental in the development and advancement of novel treatment options in the field of interventional cardiology.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Health
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related Posts

Continued vigilance is essential to protect India’s polio-free status

November 17, 2026

Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram

November 16, 2026

Aayush Wellness Launches Himalayan Shilajit Drops as Global Shilajit Market is Projected to Reach USD 436.72 Million by 2034, Growing at 8.67% CAGR

November 16, 2026

Comments are closed.

Top Posts

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Don't Miss
Finance

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

By Arjun SinghNovember 17, 2026

Dehradun (Uttarakhand) [India], November 17: Neetu Yoshi Limited (BSE: 544434), a leading manufacturer of customised…

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

November 17, 2026

India’s DeepTech Capital Needs People Who Can Put It to Work

November 17, 2026

Aahwahan Foundation Begins Cyclone Relief Drive in Odisha Distributes 30,000 Grocery & Relief Kits Across Ganjam, Malkangiri and Koraput

November 17, 2026
Most Popular

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Neetu Yoshi Reports 4.0% YoY Growth in Net Profit in H1 FY27 to Rs 12.00 Crore; Total Income Stands at Rs 59.38 Crore

November 17, 2026

Global Schools Group Opens Applications for Fully Funded Global Citizen Scholarship 2027

November 17, 2026

India’s DeepTech Capital Needs People Who Can Put It to Work

November 17, 2026

Type above and press Enter to search. Press Esc to cancel.